Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
4.250
+0.360 (9.25%)
At close: May 12, 2025, 4:00 PM
4.250
0.00 (0.00%)
After-hours: May 12, 2025, 7:58 PM EDT
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$307,889
Profits / Employee
-$37,556
Market Cap
391.75M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MYGN News
- 5 hours ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 6 days ago - Myriad Genetics, Inc. (MYGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance - GlobeNewsWire
- 10 days ago - Myriad Genetics: Significantly Undervalued With Profitability In Sight - Seeking Alpha
- 12 days ago - Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor - GlobeNewsWire
- 17 days ago - Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting - GlobeNewsWire
- 21 days ago - Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing - GlobeNewsWire
- 4 weeks ago - Myriad Genetics Announces Inducement Awards - GlobeNewsWire